Epiq Partners, LLC Vista Gen Therapeutics, Inc. Transaction History

Epiq Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 07, 2022	BUY	$0.88 - $1.73 $123,200 - $242,200	140,000 Added 12.05%	1,301,350 $1.15 Million
Q1 2022 Apr 27, 2022	BUY	$1.14 - $2.09 $181,259 - $332,310	159,000 Added 15.86%	1,161,350 $1.44 Million
Q4 2021 Jan 25, 2022	BUY	$1.67 - $2.76 $144,037 - $238,049	86,250 Added 9.41%	1,002,350 $1.96 Million
Q3 2021 Oct 19, 2021	SELL	$2.62 - $3.45 $44,162 - $58,153	-16,856 Reduced 1.81%	916,100 $2.51 Million
Q2 2021 Aug 02, 2021	BUY	$1.96 - $3.15 $99,960 - $160,650	51,000 Added 5.78%	932,956 $2.94 Million
Q1 2021 Apr 16, 2021	BUY	$1.89 - $2.96 $1.67 Million - $2.61 Million	881,956 New	881,956 $1.88 Million

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $517M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Epiq Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Epiq Partners, LLC with notifications on news.